Biomol Research Laboratoryt

Company Information
Address 5166 Campus Drive
Plymouth Meeting, PA, 19462


Information

DUNS:

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Farnesyltransferase Inhibitors As Anticancer Agents

    Amount: $50,000.00

    The goal of the research is to develop a potent, pharmacologically useful inhibitor of farnesyltransferase for use as a new therapeutic agent for cancer. The Ras family of oncogenes and proto-oncogene ...

    SBIRPhase I1993Department of Health and Human Services
  2. Tyrosine Phosphatase Inhibitors As New Immunomodulators

    Amount: $49,834.00

    The goal of the research is to develop a potent pharmacologically useful inhibitor of the CD45 protein tyrosine phosphatase. CD45 is a transmembrane protein having a highly glycosylated extracellular ...

    SBIRPhase I1993Department of Health and Human Services
  3. NOVEL ANTICANCER DRUGS BASED ON GLYCOLIPID DEPLETION

    Amount: $50,000.00

    THE GOAL OF THE RESEARCH IS TO DEVELOP A POTENT PHARMACOLOGICALLY USEFUL INHIBITOR OF GLYCOSPHINGOLIPID (GSL) BIOSYNTHESIS. GSLS PLAY IMPORTANT ROLES IN (1) CANCER CELL METASTASIS, PROLIFERATION, AND ...

    SBIRPhase I1992Department of Health and Human Services
  4. NOVEL THERAPEUTIC AGENT FOR MYOCARDIAL INFARCTION

    Amount: $50,000.00

    THE GOAL OF THIS RESEARCH IS TO DEVELOP A POTENT AND SPECIFIC PHARMACOLOGICALLY USEFUL ANTAGONIST TO THE LEUKOTRIENE B4 (LTB4) RECEPTOR FOR USE AS A NEW THERAPEUTIC AGENT IN MYOCARDIAL INFARCTION. LTB ...

    SBIRPhase I1990Department of Health and Human Services
  5. RADIO IMMUNOASSAY KITS FOR PLATELET ACTIVATING FACTOR

    Amount: $50,000.00

    THE GOAL OF THE PROPOSED RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR PLATELET ACTIVATING FACTOR (PAF). PAF IS A LIPID MEDIATOR PRODUCED BY A VARIETY OF INFLAMMATORY CEL ...

    SBIRPhase I1988Department of Health and Human Services
  6. THE GOAL OF THIS RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR LEUKOTRIENE E4 AND LEUKOTRIENE E4-N-ACETATE, TWO IMPORTANT METABOLITES OF LEUKOTRIENE C4 AND D4.

    Amount: $50,000.00

    THE GOAL OF THIS RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR LEUKOTRIENE E4 AND LEUKOTRIENE E4-N-ACETATE, TWO IMPORTANT METABOLITES OF LEUKOTRIENE C4 AND D4. THESE LEUK ...

    SBIRPhase I1986Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government